Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Genetically modified micro-organism – cell – or virus
Reexamination Certificate
2006-01-31
2006-01-31
Navarro, Mark (Department: 1645)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Genetically modified micro-organism, cell, or virus
C424S093400, C424S041000, C424S042000, C424S200100
Reexamination Certificate
active
06991786
ABSTRACT:
Novel antimicrobial agents that can serve as replacements to conventional pharmaceutical antibiotics are disclosed. The antimicrobial agents comprise conjugatively transmissible plasmids that kill targeted pathogenic bacteria, but are not harmful to donor bacteria. Two types of lethal transmissible plasmids are disclosed. One type kills recipient bacteria by unchecked (“runaway”) replication in the recipient cells and is prevented from occurring in donor cells. Another type kills recipient bacteria by expressing a gene that produces a product detrimental or lethal to recipient bacterial cells, that gene being prevented from expression in donor cells.
REFERENCES:
patent: 5399496 (1995-03-01), Fujiwara et al.
patent: 5434065 (1995-07-01), Mahan et al.
patent: 6019984 (2000-02-01), MacInnes et al.
patent: 6254874 (2001-07-01), Mekalanos et al.
patent: 6716631 (2004-04-01), delCardayre et al.
patent: 6780405 (2004-08-01), Curtiss et al.
patent: 0109150 (1984-05-01), None
Roberts et al, Journal of Bacteriology, Nov. 1990, 172 (11), p. 6204-6216).
Klimke et al, Journal of Bacteriology, Aug. 1998, 180 (16)p. 4036-4043).
Ambrozic et al, Microbiology, Feb. 1998, 144 (Pt. 2), p. 343-352.
Metcalf et al, Plasmid, 1996, 35, p. 1-13.
Rahal et al, Annales de microbiologie, 1978, 129 (4), P. 40-414.
Toukdarian et al, Gene 223, p. 205-211.
Ambrozic et al, Microbiology (England), Feb. 1998, 144(Pt2), p. 343-352.
Roberts et al, Journal of Bacteriology, Nov. 1990, 172 (11), p. 6204-6216.
Klimke et al, Journal of Bacteriology, Aug. 1998, 180 (16), p. 4036-4043.
Rahal et al, Annales de microbiologie (France), May-Jun. 1978, 129 (4), p. 409-414.
Metcalf et al, Plasmid. Jan. 1996;35(1):1-13.
Kaniga et al, Gene 109, 1991, 137-141.
Filutowicz, M. and Rakowski, S.A., Regulatory implications of protein assemblies at the γ origin of plasmid R6K—a review. Gene 223:195-204 (1998).
Kudva, I.T. et al., Biocontrol ofEscherichia coliO157 with O157-Specific Bacteriophages. Applied and Environmental Microbiology 65:3767-3773 (1999).
Lessl, M. and Lanka, E., Common Mechanism in Bacterial Conjugation and Ti-Mediated T-DNA Transfer to Plant Cells. Cell 77:321-324 (1994).
Molin, S. et al., Runaway Replication of Plasmid R1 Is Not Caused by Loss of Replication Inhibator Activity of Genecop.Journal of Bacteriology 143:1046-1048 (1980).
Reid, G., The Scientific Basis for Probiotic Strains ofLactobacillus. Applied and Environmental Microbiology 65:3763-3766 (1999).
Rodriguez, M. et al., Lethality and Survival ofKlebsiella oxytocaEvoked by Conjugative IncN Plasmids. Journal of Bacteriology 177:6352-6361 (1995).
Smith, H.W. and Huggins, M.B., Successful Treatment of ExperimentalEscherichia coliInfections in Mice Using Phage: its General Superiority over Antibiotics. Journal of General Microbiology 128:307-318 (1982).
Smith, H.W. and Huggins, M.B., Effectiveness of Phages in Treating ExperimentalEscherichia coliDiarrhoea in Calves, Piglets and Lambs. Journal of General Microbiology 129:2659-2675 (1983).
Smith, H.W. et al., The Control of ExperimentalEscherichia coliDiarrhoea in Calves by Means of Bacteriophages. Journal of General Microbiology 133:1111-1126 (1987).
Toukdarian, A.E. and Helsinki, D.R., TrfA dimers play a role in copy-number control of RK2 replication. Gene 223:205-211 (1998).
Blasina, A., et al., “Copy-up mutants of the plasmid RK2 replication initiation protein are defective in coupling RK2 replication origins,”Proc. Natl. Acad. Sci. USA,Apr. 1996, 93, 3559-3564.
Diaz, E., et al., “Universal barrier to lateral spread of specific genes among microorganisms,”Molecular Microbiology,XP 000579401, 1994, 13(5), 855-861.
Haugan, K. et al., “The Host Range of RK2 Minimal Replicon Copy-Up Mutants Is Limited by Species-Specific Differences in the Maximum Tolerable Copy Number”,Plasmid,1995, 33, 27-39.
Ford Vanessa L.
Navarro Mark
Quarles & Brady LLP
Wisconsin Alumni Research Foundation
LandOfFree
Anti-microbial biotherapeutic agents: alternatives to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anti-microbial biotherapeutic agents: alternatives to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anti-microbial biotherapeutic agents: alternatives to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3545852